QVT Associates GP LLC, 10% Owner at ANADYS PHARMACEUTICALS INC (ANDS), bought 2,258,900 shares at $1.44 ($3.0M) on 2010-12-28, disclosed to the SEC on 2010-12-29.
Open-market purchase of $3.0M ANDS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.30 | 1,714,210 | $2.2M | 74.0% |
| 2 | $1.34 | 12,200 | $16K | 0.5% |
| 3 | $1.44 | 532,490 | $767K | 25.5% |
| Total | $1.33 avg | 2,258,900 | $3.0M | 100% |
| Filing → |
| UROV | BUY | 2019-06-03 | $278K | — | Filing → |
| UROV | BUY | 2019-05-29 | $110K | — | Filing → |
| UROV | BUY | 2019-05-23 | $326K | — | Filing → |